H.R.5794

            I 

116TH CONGRESS 
2D SESSION H. R. 5794 

To amend the Public Health Service Act to expand research and education 
with respect to endometrial cancer, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 6, 2020 
Mr. DAVID SCOTT of Georgia (for himself, Ms. NORTON, Mr. COHEN, Mrs. 

BEATTY, Ms. KELLY of Illinois, Mr. BISHOP of Georgia, Mr. 
BUTTERFIELD, Mr. CARSON of Indiana, Ms. CLARKE of New York, Mr. 
THOMPSON of Mississippi, Ms. PRESSLEY, Mr. LAWSON of Florida, Mr. 
HASTINGS, Ms. BLUNT ROCHESTER, Ms. JOHNSON of Texas, Mr. GREEN 
of Texas, Ms. FUDGE, Mr. PAYNE, Ms. BASS, Ms. LEE of California, Mr. 
RUSH, Mr. BROWN of Maryland, Mr. DANNY K. DAVIS of Illinois, Mr. 
RICHMOND, Mr. JEFFRIES, Mr. MEEKS, Ms. JACKSON LEE, Mr. JOHN-
SON of Georgia, Mrs. WATSON COLEMAN, Ms. PLASKETT, and Mr. CLY-
BURN) introduced the following bill; which was referred to the Committee 
on Energy and Commerce 

A BILL 
To amend the Public Health Service Act to expand research 

and education with respect to endometrial cancer, and 
for other purposes. 

Be it enacted by the Senate and House of Representa-1

tives of the United States of America in Congress assembled, 2

SECTION 1. SHORT TITLE. 3

This Act may be cited as the ‘‘Endometrial Cancer 4

Research and Education Act of 2020’’. 5

VerDate Sep 11 2014 03:56 Feb 08, 2020 Jkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H5794.IH H5794kjo
hn

so
n 

on
 D

S
K

79
L0

C
42

P
R

O
D

 w
ith

 B
IL

LS



2 

•HR 5794 IH

SEC. 2. FINDINGS. 1

Congress finds the following: 2

(1) Endometrial cancer is cancer of the lining 3

of the uterus (or endometrium) and is the most com-4

mon form of uterine cancer. 5

(2) Endometrial cancer is the fourth most com-6

mon cancer diagnosed in women, after breast, lung, 7

and colon cancer. 8

(3) Endometrial cancer mainly affects post-9

menopausal women, with most women diagnosed be-10

tween age 55 and 64. 11

(4) Women with polycystic ovary syndrome 12

(PCOS) and uterine leiomyoma have an increased 13

risk of developing endometrial cancer. 14

(5) Unlike most other types of cancer, the inci-15

dence of endometrial cancer, particularly aggressive 16

subtypes of such cancer, has been increasing in the 17

United States among all women, particularly among 18

African-American and Asian women, with a 2.5 an-19

nual percent change for both groups. 20

(6) In comparison to non-Hispanic White 21

women, African-American women have significantly 22

higher incidence rates of aggressive endometrial can-23

cers. 24

VerDate Sep 11 2014 03:56 Feb 08, 2020 Jkt 099200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H5794.IH H5794kjo
hn

so
n 

on
 D

S
K

79
L0

C
42

P
R

O
D

 w
ith

 B
IL

LS



3 

•HR 5794 IH

(7) Such incidence rates for Hispanic and Asian 1

women are equal to or lower than such incidence 2

rates for non-Hispanic White women. 3

(8) Although non-Hispanic White women are 4

more likely to be diagnosed with endometrial cancer 5

in comparison to African-American women, the rate 6

of mortality is higher for African-American women. 7

(9) Currently, the cause of such disparity is un-8

known. Researchers have studied the disparity in re-9

lation to the time between diagnosis and treatment 10

of endometrial cancer, including socioeconomic fac-11

tors. 12

SEC. 3. EXPANDING RESEARCH AND EDUCATION WITH RE-13

SPECT TO ENDOMETRIAL CANCER. 14

(a) NATIONAL INSTITUTES OF HEALTH.—Part B of 15

title IV of the Public Health Service Act (42 U.S.C. 284 16

et seq.) is amended by adding at the end the following 17

new section: 18

‘‘SEC. 409K. ENDOMETRIAL CANCER. 19

‘‘(a) IN GENERAL.—The Director of NIH shall— 20

‘‘(1) expand, intensify, and coordinate programs 21

to conduct and support research with respect to 22

endometrial cancer; and 23

‘‘(2) communicate to medical professionals and 24

researchers, including through the endometrial can-25

VerDate Sep 11 2014 03:56 Feb 08, 2020 Jkt 099200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H5794.IH H5794kjo
hn

so
n 

on
 D

S
K

79
L0

C
42

P
R

O
D

 w
ith

 B
IL

LS



4 

•HR 5794 IH

cer public education program established under sec-1

tion 399V–7, the disparity in the diagnosis of 2

endometrial cancer between African-American 3

women and non-Hispanic White women and any new 4

research relating to endometrial cancer. 5

‘‘(b) COORDINATION WITH OTHER INSTITUTES.— 6

The Director of NIH shall coordinate activities carried out 7

by the Director pursuant to subsection (a) with similar 8

activities carried out by— 9

‘‘(1) the Director of the Eunice Kennedy Shriv-10

er National Institute of Child Health and Human 11

Development; 12

‘‘(2) the Director of the National Institute on 13

Minority Health and Health Disparities; and 14

‘‘(3) the Director of the Office of Research on 15

Women’s Health. 16

‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—For 17

purposes of carrying out this section, there is authorized 18

to be appropriated $500,000 for each of fiscal years 2021 19

through 2023.’’. 20

(b) CENTERS FOR DISEASE CONTROL AND PREVEN-21

TION.—Part P of title III of the Public Health Service 22

Act (42 U.S.C. 280g et seq.) is amended by adding at 23

the end the following new section: 24

VerDate Sep 11 2014 03:56 Feb 08, 2020 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H5794.IH H5794kjo
hn

so
n 

on
 D

S
K

79
L0

C
42

P
R

O
D

 w
ith

 B
IL

LS



5 

•HR 5794 IH

‘‘SEC. 399V–7. ENDOMETRIAL CANCER PUBLIC EDUCATION 1

PROGRAM. 2

‘‘(a) IN GENERAL.—The Secretary, acting through 3

the Director of the Centers for Disease Control and Pre-4

vention, shall develop and disseminate to the public infor-5

mational materials on endometrial cancer, including the 6

incidence rate of such cancer, the risk factors for devel-7

oping such cancer, the increased risk for ethnic minority 8

women to develop such cancer, and the range of available 9

treatments for such cancer. Any informational material 10

developed pursuant to the previous sentence may be trans-11

mitted to a nonprofit organization; institution of higher 12

education; Federal, State, or local agency; or media entity 13

for purposes of disseminating such material to the public. 14

‘‘(b) CONSULTATION.—In developing and dissemi-15

nating informational materials under subsection (a), the 16

Director of the Centers for Disease Control and Preven-17

tion shall consult with the Administrator of the Health 18

Resources and Services Administration. 19

‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—For 20

purposes of carrying out this section, there is authorized 21

to be appropriated such sums as may be necessary for 22

each of fiscal years 2021 through 2023.’’. 23

Æ 

VerDate Sep 11 2014 03:56 Feb 08, 2020 Jkt 099200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6301 E:\BILLS\H5794.IH H5794kjo
hn

so
n 

on
 D

S
K

79
L0

C
42

P
R

O
D

 w
ith

 B
IL

LS


<<
  /ASCII85EncodePages false
  /AllowTransparency false
  /AutoPositionEPSFiles true
  /AutoRotatePages /None
  /Binding /Left
  /CalGrayProfile (Dot Gain 20%)
  /CalRGBProfile (sRGB IEC61966-2.1)
  /CalCMYKProfile (U.S. Web Coated \050SWOP\051 v2)
  /sRGBProfile (sRGB IEC61966-2.1)
  /CannotEmbedFontPolicy /Error
  /CompatibilityLevel 1.4
  /CompressObjects /Off
  /CompressPages true
  /ConvertImagesToIndexed true
  /PassThroughJPEGImages true
  /CreateJobTicket false
  /DefaultRenderingIntent /Default
  /DetectBlends true
  /DetectCurves 0.0000
  /ColorConversionStrategy /LeaveColorUnchanged
  /DoThumbnails false
  /EmbedAllFonts true
  /EmbedOpenType false
  /ParseICCProfilesInComments true
  /EmbedJobOptions true
  /DSCReportingLevel 0
  /EmitDSCWarnings false
  /EndPage -1
  /ImageMemory 1048576
  /LockDistillerParams true
  /MaxSubsetPct 100
  /Optimize false
  /OPM 1
  /ParseDSCComments true
  /ParseDSCCommentsForDocInfo true
  /PreserveCopyPage true
  /PreserveDICMYKValues true
  /PreserveEPSInfo true
  /PreserveFlatness true
  /PreserveHalftoneInfo false
  /PreserveOPIComments true
  /PreserveOverprintSettings true
  /StartPage 1
  /SubsetFonts false
  /TransferFunctionInfo /Preserve
  /UCRandBGInfo /Preserve
  /UsePrologue true
  /ColorSettingsFile ()
  /AlwaysEmbed [ true
  ]
  /NeverEmbed [ true
  ]
  /AntiAliasColorImages false
  /CropColorImages true
  /ColorImageMinResolution 300
  /ColorImageMinResolutionPolicy /OK
  /DownsampleColorImages false
  /ColorImageDownsampleType /Bicubic
  /ColorImageResolution 300
  /ColorImageDepth 8
  /ColorImageMinDownsampleDepth 1
  /ColorImageDownsampleThreshold 1.50000
  /EncodeColorImages true
  /ColorImageFilter /FlateEncode
  /AutoFilterColorImages false
  /ColorImageAutoFilterStrategy /JPEG
  /ColorACSImageDict <<
    /QFactor 0.15
    /HSamples [1 1 1 1] /VSamples [1 1 1 1]
  >>
  /ColorImageDict <<
    /QFactor 0.15
    /HSamples [1 1 1 1] /VSamples [1 1 1 1]
  >>
  /JPEG2000ColorACSImageDict <<
    /TileWidth 256
    /TileHeight 256
    /Quality 30
  >>
  /JPEG2000ColorImageDict <<
    /TileWidth 256
    /TileHeight 256
    /Quality 30
  >>
  /AntiAliasGrayImages false
  /CropGrayImages true
  /GrayImageMinResolution 300
  /GrayImageMinResolutionPolicy /OK
  /DownsampleGrayImages false
  /GrayImageDownsampleType /Bicubic
  /GrayImageResolution 300
  /GrayImageDepth 8
  /GrayImageMinDownsampleDepth 2
  /GrayImageDownsampleThreshold 1.50000
  /EncodeGrayImages true
  /GrayImageFilter /FlateEncode
  /AutoFilterGrayImages false
  /GrayImageAutoFilterStrategy /JPEG
  /GrayACSImageDict <<
    /QFactor 0.15
    /HSamples [1 1 1 1] /VSamples [1 1 1 1]
  >>
  /GrayImageDict <<
    /QFactor 0.15
    /HSamples [1 1 1 1] /VSamples [1 1 1 1]
  >>
  /JPEG2000GrayACSImageDict <<
    /TileWidth 256
    /TileHeight 256
    /Quality 30
  >>
  /JPEG2000GrayImageDict <<
    /TileWidth 256
    /TileHeight 256
    /Quality 30
  >>
  /AntiAliasMonoImages false
  /CropMonoImages true
  /MonoImageMinResolution 1200
  /MonoImageMinResolutionPolicy /OK
  /DownsampleMonoImages false
  /MonoImageDownsampleType /Bicubic
  /MonoImageResolution 1200
  /MonoImageDepth -1
  /MonoImageDownsampleThreshold 1.50000
  /EncodeMonoImages true
  /MonoImageFilter /CCITTFaxEncode
  /MonoImageDict <<
    /K -1
  >>
  /AllowPSXObjects false
  /CheckCompliance [
    /None
  ]
  /PDFX1aCheck true
  /PDFX3Check false
  /PDFXCompliantPDFOnly true
  /PDFXNoTrimBoxError false
  /PDFXTrimBoxToMediaBoxOffset [
    0.00000
    0.00000
    0.00000
    0.00000
  ]
  /PDFXSetBleedBoxToMediaBox true
  /PDFXBleedBoxToTrimBoxOffset [
    0.00000
    0.00000
    0.00000
    0.00000
  ]
  /PDFXOutputIntentProfile (U.S. Web Coated \050SWOP\051 v2)
  /PDFXOutputConditionIdentifier (CGATS TR 001)
  /PDFXOutputCondition ()
  /PDFXRegistryName (http://www.color.org)
  /PDFXTrapped /False

  /CreateJDFFile false
  /Description <<
    /ARA 
    /BGR 
    /CHS 
    /CHT 
    /CZE 
    /DAN 
    /DEU 
    /ESP 
    /ETI 
    /FRA 
    /GRE 
    /HEB 
    /HRV 
    /HUN 
    /ITA (Utilizzare queste impostazioni per creare documenti Adobe PDF che devono essere conformi o verificati in base a PDF/X-1a:2001, uno standard ISO per lo scambio di contenuto grafico. Per ulteriori informazioni sulla creazione di documenti PDF compatibili con PDF/X-1a, consultare la Guida dell'utente di Acrobat. I documenti PDF creati possono essere aperti con Acrobat e Adobe Reader 4.0 e versioni successive.)
    /JPN 
    /KOR 
    /LTH 
    /LVI 
    /NLD (Gebruik deze instellingen om Adobe PDF-documenten te maken die moeten worden gecontroleerd of moeten voldoen aan PDF/X-1a:2001, een ISO-standaard voor het uitwisselen van grafische gegevens. Raadpleeg de gebruikershandleiding van Acrobat voor meer informatie over het maken van PDF-documenten die compatibel zijn met PDF/X-1a. De gemaakte PDF-documenten kunnen worden geopend met Acrobat en Adobe Reader 4.0 en hoger.)
    /NOR 
    /POL 
    /PTB 
    /RUM 
    /RUS 
    /SKY 
    /SLV 
    /SUO 
    /SVE 
    /TUR 
    /UKR 
    /ENU (Use these settings to create Adobe PDF documents that are to be checked or must conform to PDF/X-1a:2001, an ISO standard for graphic content exchange.  For more information on creating PDF/X-1a compliant PDF documents, please refer to the Acrobat User Guide.  Created PDF documents can be opened with Acrobat and Adobe Reader 4.0 and later.)
  >>
  /Namespace [
    (Adobe)
    (Common)
    (1.0)
  ]
  /OtherNamespaces [
    <<
      /AsReaderSpreads false
      /CropImagesToFrames true
      /ErrorControl /WarnAndContinue
      /FlattenerIgnoreSpreadOverrides false
      /IncludeGuidesGrids false
      /IncludeNonPrinting false
      /IncludeSlug false
      /Namespace [
        (Adobe)
        (InDesign)
        (4.0)
      ]
      /OmitPlacedBitmaps false
      /OmitPlacedEPS false
      /OmitPlacedPDF false
      /SimulateOverprint /Legacy
    >>
    <<
      /AddBleedMarks false
      /AddColorBars false
      /AddCropMarks false
      /AddPageInfo false
      /AddRegMarks false
      /ConvertColors /ConvertToCMYK
      /DestinationProfileName ()
      /DestinationProfileSelector /DocumentCMYK
      /Downsample16BitImages true
      /FlattenerPreset <<
        /PresetSelector /HighResolution
      >>
      /FormElements false
      /GenerateStructure false
      /IncludeBookmarks false
      /IncludeHyperlinks false
      /IncludeInteractive false
      /IncludeLayers false
      /IncludeProfiles false
      /MultimediaHandling /UseObjectSettings
      /Namespace [
        (Adobe)
        (CreativeSuite)
        (2.0)
      ]
      /PDFXOutputIntentProfileSelector /DocumentCMYK
      /PreserveEditing true
      /UntaggedCMYKHandling /LeaveUntagged
      /UntaggedRGBHandling /UseDocumentProfile
      /UseDocumentBleed false
    >>
  ]
>> setdistillerparams
<<
  /HWResolution [2400 2400]
  /PageSize [612.000 792.000]
>> setpagedevice



		Superintendent of Documents
	2020-02-12T04:16:20-0500
	US GPO, Washington, DC 20401
	Superintendent of Documents
	GPO attests that this document has not been altered since it was disseminated by GPO